CN Patent

CN101316626A — 用于降低血压的方法

Assigned to Fibrogen Inc · Expires 2008-12-03 · 17y expired

What this patent protects

本发明涉及用于降低血压的方法和药剂。本发明还提供用于降低舒张压、用于降低收缩压和用于降低平均动脉压的方法和药剂。

USPTO Abstract

本发明涉及用于降低血压的方法和药剂。本发明还提供用于降低舒张压、用于降低收缩压和用于降低平均动脉压的方法和药剂。

Drugs covered by this patent

angiotensin-ii-acetate (ANGIOTENSIN II ACETATE)

Patent Metadata

Patent number: CN101316626A
Jurisdiction: CN
Classification: —
Expires: 2008-12-03
Drug substance claim: No
Drug product claim: No
Assignee: Fibrogen Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.